Dashboard Overview
Welcome back, Dr. Johnson. Here's your clinical trial summary.
Active Trials
3
+1 this month
Currently participating
Total Patients
35
+5 this week
Enrolled across all trials
Monthly Revenue
$25,000
+13.5% from last month
June 2024
Retention Rate
99.2%
Above industry average
Patient retention
Monthly Revenue Trend
Patient Enrollment
Active Trials
Cardiovascular Prevention Study
active
ID: CT-2024-001Sponsor: PfizerPhase: Phase IIINext Visit: 2024-01-15
Enrolled
15/20
Diabetes Management Trial
recruiting
ID: CT-2024-002Sponsor: TakedaPhase: Phase IINext Visit: 2024-01-18
Enrolled
8/12
Hypertension Treatment Study
active
ID: CT-2024-003Sponsor: NovartisPhase: Phase IIINext Visit: 2024-01-20
Enrolled
12/15
Recent Activity
Patient enrollment completed
CT-2024-001 - Cardiovascular Prevention Study
2 hours ago
Protocol amendment received
CT-2024-002 - Diabetes Management Trial
1 day ago
Site visit scheduled
CT-2024-003 - Hypertension Treatment Study
3 days ago